PROGRAM CHAIR
Geoffrey C. Wall, PharmD, FCCP, BCPS
John R. Ellis Distinguished Chair of Pharmacy Practice
Professor of Clinical Sciences
Director, Drake Drug Information Center
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Des Moines, IA
SPEAKING FACULTY
Kristin S. Meyer, PharmD, BCGP, FASCP
Professor of Pharmacy Practice
College of Pharmacy and Health Sciences
Drake University
Des Moines, IA
PROGRAM OVERVIEW
This educational initiative is designed for pharmacists in the United States and globally who are involved in the care of patients with early symptomatic Alzheimer’s disease (MCI due to AD, or mild dementia due to AD). It uses a multi-component platform – the DETECT Initiative – to increase learner ability to: review evolving clinical data informing the use of anti-amyloid therapeutics (ATTs) in the care of patients with AD, including mechanisms, efficacy, safety, and dosing and administration best practices; apply best practices for individualized patient counseling to ensure adequate monitoring and management in the provision of ATTs; design guideline-informed evidence-based protocols for preparation, dosing, and scheduling of ATTs in the clinical settings; and facilitate the management of financial and reimbursement issues for patients receiving ATTs.
TARGET AUDIENCE
The intended audience includes pharmacists in the United States and globally involved in the care of patients with early symptomatic Alzheimer’s disease (MCI due to AD, or mild dementia due to AD).
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Review evolving clinical data informing the use of anti-amyloid therapeutics (ATTs) in the care of patients with AD, including mechanisms, efficacy, safety, and dosing and administration best practices
- Apply best practices for individualized patient counseling to ensure adequate monitoring and management in the provision of ATTs
- Design guideline-informed evidence-based protocols for preparation, dosing, and scheduling of ATTs in the clinical settings
- Facilitate the management of financial and reimbursement issues for patients receiving ATTs
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
EACCME Credit Designation Statement
The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at [email protected].
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Med Learning Group designates this activity for a maximum of 1.0 knowledge-based CPE contact hour.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
Statements of Credit for Non-U.S. licensed Pharmacists and Pharmacy Technicians and/or Health Care Professionals Other than Pharmacists/Pharmacy Technicians
For non-U.S. licensed pharmacists and pharmacy technicians and/or other health care professionals, the provider shall give evidence to each learner, in the form of a statement of credit of successful completion of the CPE activity within 60 days of participation in the CPE activity. Completed and signed statements of credit are distributed only following the completion of the activity within the time frame stated by the provider (e.g., on promotional materials). Incomplete or blank statements of credit must not be distributed.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Geoffrey C. Wall, PharmD | Discloses being on the speaker’s bureau for Janssen Pharmaceuticals. |
| Kristin S. Meyer, PharmD | Nothing to disclose. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Senior Vice President of Operations for Med Learning Group, has nothing to disclose.
- Debra Gordon, Medical Director for Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
- Lauren Bartunek, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Heather Gee, Program Coordinator for Med Learning Group, has nothing to disclose.
- Shannon Mutch, MS, RN, OCN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA- approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: March 12, 2025
EXPIRATION DATE: March 12, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
